Form 4 for TWST Twist Bioscience Corp
Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-05 · accession 0001214659-24-021151 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-30 | 2024-12-05 | TWST | CHESS ROBERT | Dir | S - Sale+OE | $51.85 | -3,504 | 22.4K | -14% | -$181.7K |
| D | 2024-12-30 | 2024-12-05 | TWST | CHESS ROBERT | Dir | M - OptEx | $8.82 | +3,504 | 25.1K | +16% | +$30.9K |
| D | 2024-12-30 | 2024-12-05 | TWST | CHESS ROBERT | Dir | M - OptEx | $0.00 | -3,504 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-05 | S | D | 709 | $52.45 | 21,641 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 12, 2024. (F3) Represents the weighted average sales price per share. The shares sold at prices ranging from $52.37 to $52.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 2 | Common | Common Stock | 2024-12-05 | M | A | 3,504 | $8.82 | 25,145 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 12, 2024. |
| 3 | Common | Common Stock | 2024-12-05 | S | D | 2,795 | $51.70 | 22,350 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 12, 2024. (F2) Represents the weighted average sales price per share. The shares sold at prices ranging from $51.25 to $52.04 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 4 | Derivative | Stock Option (right to buy) | 2024-12-05 | M | D | 3,504 | $0.00 | 0 | D | $8.82 · — to 2027-09-28 | 3,504 Common Stock | (F5) The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |